Clinical Trials Logo

Recurrent Glioblastoma Planned for Reoperation clinical trials

View clinical trials related to Recurrent Glioblastoma Planned for Reoperation.

Filter by:
  • None
  • Page 1

NCT ID: NCT00715013 Completed - Clinical trials for Recurrent Glioblastoma Planned for Reoperation

Patupilone (EPO 906) in Patients With Recurrent or Progressive Glioblastoma

Start date: July 2008
Phase: Phase 1/Phase 2
Study type: Interventional

Patupilone trial for patients with recurrent glioblastoma, which are planned for re-operation. Objectives: prolongation of PFS compared to patients with re-operation only, Patupilone tumor concentrations, pharmacokinetic, Perfusion in MRI pre - and post Patupilone. Translational research of tumor tissue exposed to patupilone. - Trial with medicinal product